CS
CORV

Credit Suisse’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Credit Suisse’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-115,000
Closed -$317K – 4183
2016
Q4 		$317K Buy
+115,000
New +$329K ﹤0.01% 3637

Other funds holding CORV

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.23B AUM 51.32% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
AIS
AlphaOne Investment Services West Chester, Pennsylvania $79.5M AUM 49.42% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Credit Suisse's CORV Position: Q1 2017 in Review

Credit Suisse sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q1 2017, closing a stake of 115,000 shares — an estimated $317K sold.

Credit Suisse first reported a position in CORV in Q4 2016 and held it in 1 quarter. The position peaked at $317K in Q4 2016. 32 funds tracked by Wall St. Rank hold CORV as of Q1 2017.

  • Credit Suisse reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q1 2017 after selling out during the quarter.
  • Credit Suisse sold 115,000 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q1 2017, an estimated $317K.
  • Credit Suisse first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q4 2016 and held it in 1 quarter.
  • Credit Suisse's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $317K in Q4 2016.
  • 32 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q1 2017.

Based on Credit Suisse's 13F filing for Q1 2017, filed 15 May 2017.